Table 2

Serum lipoprotein lipid concentrations (mmol/l), apolipoprotein AI and B (mg/dl), Lp(a) lipoprotein (mg/dl), and blood pressure (mm Hg) in 59 patients treated with simvastatin randomised to receive omega-3 PUFA (Omacor) or placebo for 24 weeks after which 46 patients received omega-3 PUFA for a further 24 weeks

  • Mean (SD) except Lp(a) lipoprotein, which is median (range).

  • Significantly different from their baseline values on paired testing:

  • 2-150 p < 0.025;

  • 2-160 p < 0.005;

  • 2-165 p < 0.0005.

  • Results of analysis of covariance are shown in fig 1.